US Biosimilar Market Report 2022: Patent Expiry of Biologics Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Biosimilar Market: Insights & Forecast with Potential Impact of COVID- 19 (2022-2026)” report has been added to ResearchAndMarkets.com’s offering. The US biosimilar market is forecasted to reach US$36.16 billion in 2026, experiencing growth at a CAGR of 40.16% during the period spanning from 2022 to 2026. Growth in the US biosimilar market … [Read more…]
